In recent years there has been a growing interest in the biological activity of red beetroot (Beta vulgaris rubra) and its potential utility as a health promoting and disease preventing functional food. As a source of nitrate, beetroot ingestion provides a natural means of increasing in vivo nitric oxide (NO) availability and has emerged as a potential strategy to prevent and manage pathologies associated with diminished NO bioavailability, notably hypertension and endothelial function. Beetroot is also being considered as a promising therapeutic treatment in a range of clinical pathologies associated with oxidative stress and inflammation. Its constituents, most notably the betalain pigments, display potent antioxidant, anti-inflammatory and chemo-preventive activity in vitro and in vivo. The purpose of this review is to discuss beetroot’s biological activity and to evaluate evidence from studies that specifically investigated the effect of beetroot supplementation on inflammation, oxidative stress, cognition and endothelial function.

Eestyle swimming; however, there is limited information with regard to the key strength and power variables that influence start performance during sprint swimming. In light of the above, this study aimed to examine the key strength and power predicators of start performance in 50-m freestyle swimming. Eleven male British international sprint swimmers (age 21.3 ± 1.7 years; mass 78.1 ± 11.2 kg; and height 1.8 ± 0.1 m) participated in this study. Within 1 week, swimmers performed the following tests: 3 repetition maximum (3RM) squat strength, countermovement jump (CMJ) on a portable force platform, and a measure of start time performance (time to 15 m under 50-m freestyle conditions). The start time was measured using a standard racing platform to which a portable force platform was mounted, and all starts were recorded using 2 cameras. This setup allowed for the quantification of time to 15 m, peak vertical force (PVF), and peak horizontal force (PHF). Data were analyzed using Pearson's product moment correlation with significance set at p < 0.05. Start time was significantly related to 1RM strength (r = −0.74), jump height (r = −0.69), peak (r = −0.85), and relative power (r = −0.66) (p < 0.05) but not rate of force development (r = −0.56, p > 0.05). Furthermore, lower body strength was a key determinant of jump height (r = 0.69), power (r = 0.78), PVF (r = 0.62), and PHF (r = 0.71) (p < 0.05). This study provides evidence of the importance of lower body strength and power to start time in international 50-m sprint swimmers....

25(11): 3070–3075, 2011—There is considerable conflict within the literature regarding the relevance of isometric testing for the assessment of neuromuscular function within dynamic sports. The aim of this study was to determine the relationship between isometric measures of force development and dynamic performance. Thirty-nine professional rugby league players participated in this study. Forty-eight hours after trial familiarization, participants performed a maximal isometric midthigh pull, with ∼120–130° bend at the knee, countermovement jump (CMJ), and a 10-m sprint. Force–time data were processed for peak force (PF), force at 100 milliseconds (F100ms), and peak rate of force development (PRFD). Analysis was carried out using Pearson's product moment correlation with significance set at p < 0.05. The PF was not related to dynamic performance; however, when expressed relative to body weight, it was significantly correlated with both 10-m time and CMJ height (r = −0.37 and 0.45, respectively, p < 0.05). The F100ms was inversely related to 10-m time (r = −0.54, p < 0.01); moreover, when expressed relative to body weight, it was significantly related to both 10-m time and CMJ height (r = −0.68 and 0.43, p < 0.01). In addition, significant correlations were found between PRFD and 10-m time (r = −0.66, p < 0.01) and CMJ height (r = 0.387, p < 0.01). In conclusion, this study provides evidence that measures of maximal strength and explosiveness from isometric force–time curves are related to jump and sprint acceleration performance in professional rugby league players....

Background: Randomized controlled trials (RCTs) suggest that supplementation with omega-3 polyunsaturated fatty acids (n-3PUFAs) may favourably modify cardiometabolic biomarkers in type 2 diabetes (T2DM). Previous meta-analyses are limited by insufficient sample sizes and omission of meta-regression techniques, and a large number of RCTs have subsequently been published since the last comprehensive meta-analysis. Updated information regarding the impact of dosage, duration or an interaction between these two factors is therefore warranted. The objective was to comprehensively assess the effect of n-3PUFAs supplementation on cardiometabolic biomarkers including lipid profiles, inflammatory parameters, blood pressure, and indices of glycaemic control, in people with T2DM, and identify whether treatment dosage, duration or an interaction thereof modify these effects. Methods: Databases including PubMed and MEDLINE were searched until 13th July 2017 for RCTs investigating the effect of n-3PUFAs supplementation on lipid profiles, inflammatory parameters, blood pressure, and indices of glycaemic control. Data were pooled using random-effects meta-analysis and presented as standardised mean difference (Hedges g) with 95% confidence intervals (95% CI). Meta-regression analysis was performed to investigate the effects of duration of supplementation and total dosage of n-3PUFAs as moderator variables where appropriate. Results: A total of 45 RCTs were identified, involving 2674 people with T2DM. n-3PUFAs supplementation was associated with significant reductions in LDL [ES: − 0.10, (95% CI − 0.17, − 0.03); p = 0.007], VLDL (ES: − 0.26 (− 0.51, − 0.01); p = 0.044], triglycerides (ES: − 0.39 (− 0.55, − 0.24; p ≤ 0.001] and HbA1c (ES: − 0.27 (− 0.48, − 0.06); p = 0.010]. Moreover, n-3PUFAs supplementation was associated with reduction in plasma levels of TNF-α [ES: − 0.59 (− 1.17, − 0.01); p = 0.045] and IL-6 (ES: − 1.67 (− 3.14, − 0.20); p = 0.026]. All other lipid markers, indices of glycaemic control, inflammatory parameters, and blood pressure remained unchanged (p > 0.05). Conclusions: n-3PUFAs supplementation produces favourable hypolipidemic effects, a reduction in pro-inflammatory cytokine levels and improvement in glycaemia. Neither duration nor dosage appear to explain the observed heterogeneity in response to n-3PUFAs. Trial registration This trial was registered at http://www.crd.york.ac.uk as CRD42016050802

This study assessed the positional and temporal movement patterns of professional rugby union players during competition using global positioning system (GPS) units. GPS data were collected from 33 professional rugby players from 13 matches throughout the 2012–2013 season sampling at 10 Hz. Players wore GPS units from which information on distances, velocities, accelerations, exertion index, player load, contacts, sprinting and repeated high‐intensity efforts (RHIE) were derived. Data files from players who played over 60 min (n = 112) were separated into five positional groups (tight and loose forwards; half, inside and outside backs) for match analysis. A further comparison of temporal changes in movement patterns was also performed using data files from those who played full games (n = 71). Significant positional differences were found for movement characteristics during performance (P < 0.05). Results demonstrate that inside and outside backs have greatest high‐speed running demands; however, RHIE and contact demands are greatest in loose forwards during match play. Temporal analysis of all players displayed significant differences in player load, cruising and striding between halves, with measures of low‐ and high‐intensity movement and acceleration/deceleration significantly declining throughout each half. Our data demonstrate significant positional differences for a number of key movement variables which provide a greater understanding of positional requirements of performance. This in turn may be used to develop progressive position‐specific drills that elicit specific adaptations and provide objective measures of preparedness. Knowledge of performance changes may be used when developing drills and should be considered when monitoring and evaluating performance.

Sports scientists and strength and conditioning professionals spend the majority of the competition season trying to ensure that their athletes’ training and recovery strategies are appropriate to ensure optimal performance on competition day. However, there is an additional window on the day of competition where performance can be acutely enhanced with a number of preconditioning strategies. These strategies include appropriately designed warm-up, passive heat maintenance, postactivation potentiation, remote ischemic preconditioning, and, more recently, prior exercise and hormonal priming. The aim of this review was to explore the potential practical use of these strategies and propose a theoretical timeline outlining how they may be incorporated into athlete’s precompetition routine to enhance performance. For the purpose of this review the discussion is confined to strategies that may enhance performance of short-duration, high-intensity sports (eg, sprinting, jumping, throwing).